Expression of phosphorylated forms of ERK, MEK, PTEN and PI3K in mouse oral development

被引:15
作者
Cho, Kyoung-Won [1 ]
Cho, Sung-Won [1 ]
Lee, Jong-Min [1 ]
Lee, Min-Jung [1 ]
Gang, Hee-Seok [1 ]
Jung, Han-Sung [1 ]
机构
[1] Yonsei Univ, Div Anat & Dev Biol,Brain Korea Project 21, Dept Oral Biol,Oral Sci Res Ctr,Yonsei Ctr Biotec, Res Ctr Orofacial Hard Tissue Regenerat,Coll Dent, Seoul 120752, South Korea
关键词
pERK; pMEK; pPTEN; pPI3K; tooth; oral development;
D O I
10.1016/j.gep.2007.12.001
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Investigations into molecular mechanisms in vertebrates have examined which growth factors regulate many of the essential underlying cellular processes in development. Growth factors regulate cell proliferation and differentiation through diverse signaling pathways like the MEK (mitogen-activated protein kinase) and ERK (extracellular signal-regulated kinase) pathway. The MEK and ERK pathway can interact with the PI3K (phosphatidylinositol-3-kinase) and PTEN (phosphatase and tensin homologues deleted on chromosome 10) signaling pathway. Interactions between these pathways during development have been extensively studied in many organs; however, the importance of these pathways in oral development is not well known. In this study, we examined the expression of the phosphorylated forms of ERK (pERK), MEK (pMEK), PTEN (pPTEN) and PI3K during mouse development from E13.5 to E16.5. We found unique and overlapping expression of these factors in the cramofacial region, with pERK and pPTEN showing opposing activation patterns in both the tooth and the tongue. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:284 / 290
页数:7
相关论文
共 10 条
[1]   Adhesion-related kinase repression of gonadotropin-releasing hormone gene expression requires Rac activation of the extracellular signal-regulated kinase pathway [J].
Allen, MP ;
Xu, M ;
Linseman, DA ;
Pawlowski, JE ;
Bokoch, GM ;
Heidenreich, KA ;
Wierman, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38133-38140
[2]   Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[3]   Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation [J].
Ghosh-Choudhury, Nandini ;
Mandal, Chandi Charan ;
Choudhury, Goutam Ghosh .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (07) :4983-4993
[4]   TP508 accelerates fracture repair by promoting cell growth over cell death [J].
Li, Xinmin ;
Wang, Hali ;
Touma, Edward ;
Qi, Yuchen ;
Rousseau, Emma ;
Quigg, Richard J. ;
Ryaby, James T. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 364 (01) :187-193
[5]   SPECIFICITY OF RECEPTOR TYROSINE KINASE SIGNALING - TRANSIENT VERSUS SUSTAINED EXTRACELLULAR SIGNAL-REGULATED KINASE ACTIVATION [J].
MARSHALL, CJ .
CELL, 1995, 80 (02) :179-185
[6]   Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance [J].
McCubrey, James A. ;
Steelman, Linda S. ;
Abrams, Steven L. ;
Lee, John T. ;
Chang, Fumin ;
Bertrand, Fred E. ;
Navolanic, Patrick M. ;
Terrian, David M. ;
Franklin, Richard A. ;
D'Assoro, Antonio B. ;
Salisbury, Jeffrey L. ;
Mazzarino, Maria Clorinda ;
Stivala, Franca ;
Libra, Massimo .
ADVANCES IN ENZYME REGULATION, VOL 46, PROCEEDINGS, 2006, 46 :249-279
[7]   MAP kinase modules: Many roads home [J].
Raman, M ;
Cobb, MH .
CURRENT BIOLOGY, 2003, 13 (22) :R886-R888
[8]   Cell Signaling by Receptor Tyrosine Kinases [J].
Lemmon, Mark A. ;
Schlessinger, Joseph .
CELL, 2010, 141 (07) :1117-1134
[9]   Negative feedback predominates over cross-regulation to control ERK MAPK activity in response to FGF signalling in embryos [J].
Smith, Terence Gordon ;
Karlsson, Maria ;
Lunn, J. Simon ;
Eblaghie, Maxwell C. ;
Keenan, Iain D. ;
Farrell, Elizabeth R. ;
Tickle, Cheryll ;
Storey, Kate G. ;
Keyse, Stephen M. .
FEBS LETTERS, 2006, 580 (17) :4242-4245
[10]   The complexity of PTEN: mutation, marker and potential target for therapeutic intervention [J].
Steelman, LS ;
Bertrand, FE ;
McCubrey, JA .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2004, 8 (06) :537-550